Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PGA-4HGF may help treat hair loss by activating hair growth pathways and extending the hair growth phase.

Miniaturized hair follicles in androgenetic alopecia show abnormal mitochondrial activity and damage.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.

New treatments for hair loss focus on targeting specific causes to improve effectiveness and safety.

Postmenopausal hyperandrogenism involves excess male hormones causing symptoms like hair growth and acne, and requires ruling out tumors and other disorders.

Allopregnanolone may help reduce inflammation and symptoms related to post-finasteride syndrome.

Hutchinson-Gilford Progeria Syndrome causes rapid aging from a genetic mutation, with no cure but ongoing research into potential treatments.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

TAZ boosts fat cell formation in goat stem cells by activating a specific signaling pathway.

Androgen receptor differences may contribute to hair loss in AGA patients.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Androgen-producing ovarian tumors can cause male-pattern hair loss in women.

Higher GPER-1 levels are linked to more severe and shorter-duration androgenetic alopecia, suggesting GPER-1 as a potential treatment target.

Padina arborescens and its component MOGG may help prevent hair loss through several actions, including blocking a hair loss-related enzyme.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

A woman with Degos disease managed her condition for nine years with medications and had two healthy pregnancies, while a separate finding suggests a possible link between female pattern hair loss and high blood pressure.

Patients with androgenetic alopecia often have abnormal lipid levels, so they should be screened and advised on lifestyle changes to prevent heart issues.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Apoptosis contributes to hair loss in androgenetic alopecia.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

A patient with "strawberry gingivitis" improved after correct treatment for Granulomatosis with polyangiitis, highlighting the need for early diagnosis.

GLP-1 receptor agonists may cause hair loss, but regrowth is rare.

Women with PCOS have lower ghrelin levels and a weaker response to sugar, which might affect their feeling of fullness and lead to overeating.